Platelet-neutrophil-interactions: Linking hemostasis and inflammation

被引:494
作者
Zarbock, Alexander
Polanowska-Grabowska, Renata K.
Ley, Klaus
机构
[1] Univ Virginia, Robert M Berne Cardiovasc Res Ctr, Charlottesville, VA USA
[2] Univ Virginia, Dept Physiol & Biol Phys, Charlottesville, VA USA
[3] Univ Virginia, Dept Biomed Engn, Charlottesville, VA USA
[4] Univ Virginia, Dept Biochem & Mol Genet, Charlottesville, VA USA
[5] Univ Munster, Dept Anesthesiol & Intens Care Med, D-4400 Munster, Germany
关键词
platelet-neutrophil-interactions; hemostasis; inflammation;
D O I
10.1016/j.blre.2006.06.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets are essential for primary hemostasis, but they also play an important pro-inflammatory rote. Platelets normally circulate in a quiescent state. Upon activation, platelets can secrete and present various molecules, change their shape as well as the expression pattern of adhesion molecules. These changes are associated with the adhesion of platelets to leukocytes and the vessel wall. The interaction of platelets with neutrophils promotes the recruitment of neutrophils into inflammatory tissue and thus participates in host defense. This interaction of neutrophils with platelets is mainly mediated through P-selectin and beta(2) and beta(3) integrins (CD11b/CD18, CD41/CD61). Platelets can also interact with endothelial cells and monocytes. Adherent platelets promote the 'secondary capture' of neutrophils and other leukocytes. In addition, platelets secrete neutrophil and endotheliat activators inducing production of inflammatory cytokines. Thus, platelets are important amplifiers of acute inflammation. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:99 / 111
页数:13
相关论文
共 141 条
[1]   Chemokine induction of integrin adhesiveness on rolling and arrested leukocytes local signaling events or global stepwise activation? [J].
Alon, R ;
Grabovsky, V ;
Feigelson, S .
MICROCIRCULATION, 2003, 10 (3-4) :297-311
[2]   Platelets adhere to and translocate on von Willebrand factor presented by endothelium in simulated veins [J].
André, P ;
Denis, CV ;
Ware, J ;
Saffaripour, S ;
Hynes, RO ;
Ruggeri, ZM ;
Wagner, DD .
BLOOD, 2000, 96 (10) :3322-3328
[3]   Platelet physiology and thrombosis [J].
Andrews, RK ;
Berndt, MC .
THROMBOSIS RESEARCH, 2004, 114 (5-6) :447-453
[4]  
Andrews RK, 1998, HISTOL HISTOPATHOL, V13, P837, DOI 10.14670/HH-13.837
[5]   PLATELETS PRIME PMN VIA RELEASED PF4 - MECHANISM OF PRIMING AND SYNERGY WITH GM-CSF [J].
AZIZ, KA ;
CAWLEY, JC ;
ZUZEL, M .
BRITISH JOURNAL OF HAEMATOLOGY, 1995, 91 (04) :846-853
[6]  
BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
[7]  
Baigent C, 2002, BMJ-BRIT MED J, V324, P71, DOI 10.1136/bmj.324.7329.71
[8]   CYTOSKELETAL DOMAINS IN THE ACTIVATED PLATELET [J].
BEARER, EL .
CELL MOTILITY AND THE CYTOSKELETON, 1995, 30 (01) :50-66
[9]   Improved endothelial function by the thromboxane A2 receptor antagonist S 18886 in patients with coronary artery disease treated with aspirin [J].
Belhassen, L ;
Pelle, G ;
Dubois-Rande, JL ;
Adnot, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (07) :1198-1204
[10]   Structure and function of the platelet integrin αIIbβ3 [J].
Bennett, JS .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (12) :3363-3369